Heinz Schwer

Heinz Schwer

Chief Executive Officer at Sloning Bio Technology GmbH

57 year
Health Technology
Consumer Services
Health Services

Network origin in Heinz Schwer first degree

EntityEntity typeIndustry
7
Subsidiary Investment Managers 7
6
Subsidiary Miscellaneous Commercial Services 6
2
Subsidiary Biotechnology 2

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Heinz Schwer via their personal network

CompanySectorRelated peopleMain position
Investment Managers

Frank Mühlenbeck

George Rehm

Private Equity Investor

Chief Executive Officer

Electronic Equipment/Instruments

Frank Mühlenbeck

George Rehm

Chairman

Chairman

Information Technology Services

Frank Mühlenbeck

George Rehm

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Frank Mühlenbeck

George Rehm

Director/Board Member

Director/Board Member

Packaged Software

George Rehm

Director/Board Member

ADAMAS PHARMACEUTICALS, INC. Pharmaceuticals: Major

George Rehm

Director/Board Member

Miscellaneous Commercial Services

George Rehm

Director/Board Member

Miscellaneous Commercial Services

George Rehm

Director/Board Member

Packaged Software

George Rehm

Director/Board Member

Computer Processing Hardware

George Rehm

Director/Board Member

University of California, Hastings College/University

George Rehm

Graduate Degree

Ruprecht-Karls-Universität Heidelberg College/University

Stefan Herr

Doctorate Degree

Pharmaceuticals: Major

George Rehm

Director/Board Member

Medical/Nursing Services

George Rehm

Director/Board Member

Medical Specialties

George Rehm

Director/Board Member

Miscellaneous Commercial Services

Rainer Wessel

Corporate Officer/Principal

Medical Specialties

Garry Merry

Sales & Marketing

Miscellaneous Commercial Services

Garry Merry

Sales & Marketing

CURETIS N.V. Medical/Nursing Services

Frank Mühlenbeck

Director/Board Member

Universität Stuttgart College/University

Frank Mühlenbeck

Doctorate Degree

Pharmaceuticals: Major

Stefan Herr

Director/Board Member

Biotechnology

Octavian Schatz

Consultant / Advisor

Pharmaceuticals: Major

Octavian Schatz

Founder

University of Regensburg College/University

Gudrun Horn

Doctorate Degree

Ludwig-Maximilians-Universität München College/University

Jan van den Brulle

Doctorate Degree

Technische Universität München College/University

Thomas Waldmann

Doctorate Degree

Medical Specialties

Frank Mühlenbeck

Chairman

Georgetown University College/University

George Rehm

Undergraduate Degree

Pharmaceuticals: Major

Frank Mühlenbeck

Corporate Officer/Principal

MITSUBISHI RESEARCH INSTITUTE, INC. Miscellaneous Commercial Services

Frank Mühlenbeck

Corporate Officer/Principal

CONFORMIS, INC. Medical Specialties

Frank Mühlenbeck

Director/Board Member

AFFIMED N.V. Biotechnology

Frank Mühlenbeck

Director/Board Member

Steinbeis Europa Zentrum

Frank Mühlenbeck

Corporate Officer/Principal

Pharmaceuticals: Major

Stefan Herr

Director/Board Member

QIAGEN N.V. Medical Specialties

Garry Merry

Corporate Officer/Principal

Statistics

International

Germany 21
United States 18
Switzerland 3
Austria 2
United Kingdom 2

Sectoral

Health Technology 19
Commercial Services 8
Consumer Services 8
Electronic Technology 4
Technology Services 4

Operational

Director/Board Member 26
Corporate Officer/Principal 9
Private Equity Investor 8
Doctorate Degree 5
Founder 4